← Back to Patent Explorer
US3855213A Expired / Lapsed US ⏱️ 0.0 years remaining

3-heterocyclic thiomethyl-cephalosporins

Assignee: Smith Kline & French Laboratories Ltd
•
Filing: 1972-09-15
•
Granted: 1974-12-17
•
Expires: 1992-09-15
📄 Original PDF 🌐 Google Patents

Abstract

Abstract Cephalosporin compounds substituted at the 7-position with free or substituted Alpha -amino or hydroxy phenylacetamido and at the 3-position with a heterocyclic thiomethyl group are prepared by displacement of a 3-acetoxy-methyl compound with a mercaptoheterocycle or by 7-acylation. The products are antibacterial agents.

Inventors

  • 👤 G Dunn
  • 👤 J Hoover

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-04 11:00
CPC Classifications
C; C07; C07D; C07D501/00; C07D501/14; C07D501/16; C07D501/20; C07D501/24; C07D501/36; A; A61; A61K; A61K31/00; A61K31/33; A61K31/395; A61K31/54; A61K31/542; A61K31/545; C07D249/00; C07D249/02; C07D249/04

Claims Analysis

Total Claims: 13
Claim 1
Independent Claim 5 words
A COMPOUND OF THE FORMULA
Claim 2
Dependent Claim 5 words
A COMPOUND OF THE FORMULA
Claim 3
Dependent Claim 24 words
A compound as claimed in claim 1, in which R1 is triazolyl, unsubstituted or substituted with 1 or 2 lower alkyl groups or trifluoromethyl.
Claim 4
Dependent Claim 22 words
A compound as claimed in claim 2, in which R1 is 1,2,3-triazolyl, unsubstituted or substituted with 1 or 2 lower alkyl groups.
Claim 5
Dependent Claim 22 words
A compound as claimed in claim 2, in which R1 is 1,2,4-triazolyl, unsubstituted or substituted with 1 or 2 lower alkyl groups.
Claim 6
Dependent Claim 12 words
A compound as claimed in claim 3, being the compound 7-mandelamido-3-(1,2,3-triazol-4-ylthiomethyl)-3-cephem-4-carboxylic acid.
Claim 7
Dependent Claim 13 words
A compound as claimed in claim 4, being the compound 7-mandelamido-3-(4-methyl-1,2,4-triazol-3-ylthiomethyl)-3-cephem-4 -carboxylic acid.
Claim 8
Dependent Claim 13 words
A compound as claimed in claim 4, being the compound 7-mandelamido-3-(5-methyl-1,2,4-triazol-3-ylthiomethyl)-3-cephem-4 -carboxylic acid.
Claim 9
Dependent Claim 12 words
A compound as claimed in claim 4, being the coompound 7-mandelamido-3-(1,2,4-triazol-3-ylthiomethyl)-3-cephem-4-carboxylic acid.
Claim 10
Dependent Claim 13 words
A compound as claimed in claim 4, being the compound 7-mandelamido-3-(3,4-dimethyl-1,2,4-triazol-5-ylthiomethyl)-3-cephem-4 -carboxylic acid.
Claim 11
Dependent Claim 13 words
A compound as claimed in claim 3, being the compound 7-mandelamido-3-(4-methyl-1,2,3-triazol-5-ylthiomethyl)-3-cephem-4 -carboxylic acid.
Claim 12
Dependent Claim 17 words
A compound as claimed in claim 1, in which X and X1 are both other than hydrogen.
Claim 13
Dependent Claim 12 words
A compound as claimed in claim 4, being the compound 7-mandelamido-3-(1-methyl-1,2,4-triazol-3ylthiomethyl)-3-cephem-4-carboxylic acid.

References Cited (Backward Citations)

US3516997A Cited
US3489752A Cited
US3644347A Cited
US3641021A Cited
US3759904A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1977-12-16 1978-06-17 1978-12-17 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1981-12-16 1982-06-17 1982-12-17 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1985-12-16 1986-06-17 1986-12-17 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag